Integrated Computational Drug Discovery of Diosgenin‐Based Analogues as PI3K‐Targeted Breast Cancer Inhibitors: QSAR, Molecular Docking, and Molecular Dynamics Insights
Dysregulation of the phosphoinositide 3‐kinase (PI3K) signalling pathway plays a critical role in breast cancer progression, therapy resistance, and poor clinical outcomes, highlighting the need for novel PI3K‐targeted therapeutic agents. This investigation utilized an integrated computational drug discovery framew...